Opioid metabolism
- PMID: 19567715
- PMCID: PMC2704133
- DOI: 10.1016/S0025-6196(11)60750-7
Opioid metabolism
Abstract
Clinicians understand that individual patients differ in their response to specific opioid analgesics and that patients may require trials of several opioids before finding an agent that provides effective analgesia with acceptable tolerability. Reasons for this variability include factors that are not clearly understood, such as allelic variants that dictate the complement of opioid receptors and subtle differences in the receptor-binding profiles of opioids. However, altered opioid metabolism may also influence response in terms of efficacy and tolerability, and several factors contributing to this metabolic variability have been identified. For example, the risk of drug interactions with an opioid is determined largely by which enzyme systems metabolize the opioid. The rate and pathways of opioid metabolism may also be influenced by genetic factors, race, and medical conditions (most notably liver or kidney disease). This review describes the basics of opioid metabolism as well as the factors influencing it and provides recommendations for addressing metabolic issues that may compromise effective pain management. Articles cited in this review were identified via a search of MEDLINE, EMBASE, and PubMed. Articles selected for inclusion discussed general physiologic aspects of opioid metabolism, metabolic characteristics of specific opioids, patient-specific factors influencing drug metabolism, drug interactions, and adverse events.
Similar articles
-
Implications of opioid analgesia for medically complicated patients.Drugs Aging. 2010 May;27(5):417-33. doi: 10.2165/11536540-000000000-00000. Drugs Aging. 2010. PMID: 20450239 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
The clinical implications of cytochrome p450 interactions with opioids and strategies for pain management.J Pain Symptom Manage. 2012 Dec;44(6 Suppl):S15-22. doi: 10.1016/j.jpainsymman.2012.08.012. J Pain Symptom Manage. 2012. PMID: 23218232
-
The metabolism of opioid agents and the clinical impact of their active metabolites.Clin J Pain. 2011 Nov-Dec;27(9):824-38. doi: 10.1097/AJP.0b013e31821d8ac1. Clin J Pain. 2011. PMID: 21677572 Review.
-
Urine toxicology testing in chronic pain management.Postgrad Med. 2009 Jul;121(4):91-102. doi: 10.3810/pgm.2009.07.2035. Postgrad Med. 2009. PMID: 19641275 Review.
Cited by
-
Hepatic resection is associated with reduced postoperative opioid requirement.J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):307-13. doi: 10.4103/0970-9185.188827. J Anaesthesiol Clin Pharmacol. 2016. PMID: 27625476 Free PMC article.
-
Suppressor capacity of copper nanoparticles biosynthesized using Crocus sativus L. leaf aqueous extract on methadone-induced cell death in adrenal phaeochromocytoma (PC12) cell line.Sci Rep. 2020 Jul 15;10(1):11631. doi: 10.1038/s41598-020-68142-8. Sci Rep. 2020. Retraction in: Sci Rep. 2020 Nov 30;10(1):21236. doi: 10.1038/s41598-020-77741-4. PMID: 32669563 Free PMC article. Retracted.
-
Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain.Drugs. 2010 Sep 10;70(13):1719-43. doi: 10.2165/11204470-000000000-00000. Drugs. 2010. PMID: 20731478 Review.
-
Nightmares and hallucinations with aprepitant and opium powder: a suspected drug-drug interaction.Br J Clin Pharmacol. 2019 Feb;85(2):454-456. doi: 10.1111/bcp.13810. Epub 2018 Nov 26. Br J Clin Pharmacol. 2019. PMID: 30479035 Free PMC article.
-
Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients.Pharmaceuticals (Basel). 2018 Sep 18;11(3):88. doi: 10.3390/ph11030088. Pharmaceuticals (Basel). 2018. PMID: 30231578 Free PMC article.
References
-
- World Health Organization Cancer Pain Relief: With a Guide to Opioid Availability 2nd ed.Geneva, Switzerland: WHO Office of Publication; 1996.
-
- Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100(6):1573-1581 - PubMed
-
- AGS Panel on Persistent Pain in Older Persons The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50(6)(suppl):S205-S224 - PubMed
-
- American Pain Society Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis 2nd ed.Glenview, IL: American Pain Society; 2002:184
-
- Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999;354(9178):581-585 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical